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Easy Test for 
Visceral 
Leishmaniasis 
and Post–Kala-azar 
Dermal 
Leishmaniasis
To the Editor: Diagnosis of 
visceral leishmaniasis (VL), fatal if 
untreated, is complex because the 
symptoms are the same for many 
fever-associated ailments. Despite 
limitations, diagnosis remains based 
on ﬁ  nding Leishmania amastigotes in 
spleen and/or bone marrow aspirates 
(1). Sophisticated laboratory 
methods, although sensitive, are 
costly. The immunochromatographic 
strip test that uses recombinant K39 
antigen (rK39), although satisfactory 
in India, is less sensitive in Africa, 
Latin America, and Mediterranean 
regions (2). Post–kala-azar dermal 
leishmaniasis (PKDL), a sequel 
to VL in India and Africa, is often 
confused with other skin diseases 
(3,4). Diagnosis of VL in dogs in 
Latin America and Mediterranean 
countries remains confusing because 
of rampant asymptomatic infections 
and elevated antibodies against 
Leishmania spp. (5).
Earlier we reported the diagnostic 
potential of L. donovani (MHOM/
IN/83/AG83) promastigote membrane 
antigens (LAg) (3,6). Here we report 
applicability of LAg-based ELISA and 
dipstick systems even at primary health 
centers. Using randomized sampling, 
we tested samples from 122 kala-azar 
patients from India, 20 PKDL patients 
from India, and 40 VL patients from 
Brazil. VL was conﬁ  rmed by ﬁ  nding 
parasites in aspirates. Serum samples 
were collected before chemotherapy 
was given. PKDL was diagnosed as 
described (3). Control samples were 
collected from 24 healthy persons 
from non–disease-endemic areas 
in India; 15 healthy persons from 
disease-endemic areas in India; 20 
healthy persons from disease-endemic 
areas in Brazil; and 21 persons with 
Hansen disease, 7 with ﬁ  lariasis,  4 
with tuberculosis, 1 with lymphoma, 
1 with leukemia, 2 with virus-induced 
fever, and 5 with malaria. Consent 
was obtained from all human donors. 
This study was approved by Ethical 
Committee on Human Subjects at 
Indian Institute of Chemical Biology 
and the Ethical Board for Human 
Subjects and Animal Experimentation 
of the Federal University of Piauí.
We developed a diagnostic 
ELISA with modiﬁ   cations of our 
previous method (6). Microtiter 
plates were coated with 2.5 μg 
LAg at pH 7.5 (100 μL/well) and 
kept at 4°C overnight, after which 
they were blocked with 1% bovine 
serum albumin, dried, and stored at 
4°C as precoated plates. The assay 
performed at room temperature 
took ≈2.5 h. Test and control serum 
samples (1:1,000 dilution, 100 μL/
well) were applied to the plates for 
45 min and shaken occasionally. 
Horseradish peroxidase–conjugated 
goat anti-human immunoglobulin 
(Ig) G (Genei, Bangalore, India) was 
applied at 1:5,000 (100 μL/well) for 45 
min. Color development with ortho-
phenylenediamine (Sigma-Aldrich, 
St. Louis, MO, USA) was allowed 
for 5–10 min. Positive results were 
determined by comparing colors with 
those on a card previously prepared 
for positive and negative wells. 
ELISA, performed for the VL and 
PKDL patients from India, was 100% 
sensitive (percentage of patients 
with conﬁ  rmed disease and positive 
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test results) and 96.3% speciﬁ  c 
(percentage of negative controls with 
negative test results) (Figure, panel 
A); sensitivity and speciﬁ  city  were 
higher than that reported earlier (6) 
and by other studies that used crude 
leishmanial antigens (2). One sample 
from each of ﬁ  lariasis,  lymphoma, 
and disease-endemic area controls 
was marginally false positive. 
Seropositivity was diagnosed for 1 
patient who had a negative spleen 
aspirate but clinical signs of VL and 
for 1 patient who refused spleen or 
bone marrow aspiration.
To avoid any visible cross-
reaction in the dipstick assay, we 
optimized LAg concentration, test 
serum dilution, and control serum 
dilution. Optimum concentration for 
human studies is 500 μg/mL LAg, 
1:2,000 serum dilutions, 1:2,000 
horseradish peroxidase–conjugated 
goat anti-human IgG, and 15 mg 
3,3′-diaminobenzidine (Sigma-
Aldrich) as substrate in 30 mL Tris-
buffered saline. LAg was bound to a 
long nitrocellulose piece at the test 
line (line on which LAg is coated). 
Goat anti-human IgG (Genei) at 1:25 
was coated as an internal control 
line. Free sites were blocked with 
2% bovine serum albumin containing 
0.01% NaN3 and were air dried. LAg-
coated membranes were afﬁ  xed to the 
end of a plastic support (with a free 
end as handle) with double-adhesive 
tape, cut into 4-mm–wide sticks, 
and stored at room temperature. 
During the testing process at room 
temperature, dipsticks were incubated 
in diluted serum for 30 min, washed 
2×, incubated for 30 min with 
secondary antibody, washed 3×, and 
incubated in substrate solution for 1 
min. Finally, dipsticks were washed 
in water, dried on tissue paper, and 
examined for speciﬁ  c reaction. When 
stored at room temperature without 
desiccation, dipsticks performed 
consistently for 12 months. Dipsticks 
appeared equally sensitive and 
speciﬁ   c (100%) for VL from India 
and Brazil and for PKDL. Because 
internal control lines remained 
positive, analyses were considered 
valid (Figure, panel B). 
LAg dipsticks are more sensitive 
for diagnosing VL in Brazil than rK39 
(7) and cost ≈70× less (8). Although 
further validation with a larger sample 
size and healthy controls from disease-
endemic areas and controls for other 
diseases is warranted, these easy, 
simple, and low-cost methods could 
emerge as efﬁ  cient tools for diagnosis 
of VL and PKDL.
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Figure. Representative results of ELISA and dipstick testing. A) Samples underwent 
ELISA in duplicate. Upper panel, positive samples in duplicate (1–2 and 3–4) in wells 
A–H, except A1–A2 (blank), and G3–G4 and H3–H4 (negative controls). Wells in columns 
5–10 represent different negative controls in duplicate (5–6, 7–8, and 9–10), except F9–
F10, G9–G10, H9–H10, and all wells in columns 11–12 (unused wells). Lower panel, the 
reference color card: a, positive; b, negative; c, blank. B) Dipstick test results. The left band 
is the internal control line; the right band is the test line.  A color version of this ﬁ  gure is 
available online (www.cdc.gov/EID/content/17/7/1304-F.htm). LETTERS
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Ameba-associated 
Keratitis, France 
To the Editor: Amebic keratitis 
is an aggressive infection usually 
associated with soft contact lenses, 
and its poor outcome can lead to a 
corneal graft (1). Ameba can host 
ameba-resistant bacteria (2) and 
serve as a source for numerous 
organisms to exchange DNA, adapt to 
changing environments, and become 
pathogenic to the host (3). However, 
mixed keratitis caused by amebae 
in association with ameba-resistant 
pathogens is rarely seen.
A 17-year-old woman who was 
myopic and had worn soft contact 
lenses for 3 years consulted our 
ophthalmology department for pain 
and redness of the left eye that had 
persisted for 2 weeks. No visual 
loss was reported, and a slit-lamp 
examination showed a millimetric 
epithelial defect associated with a 
round stromal inﬁ  ltrate (Figure). No 
intraocular reaction was observed, 
and bacterial keratitis was diagnosed. 
Her condition improved after a 7-day 
topical  ﬂ  uoroquinolone  treatment, 
and follow-up at 13 months showed 
only a slight superﬁ  cial stromal scar. 
The patient reported that she had 
inappropriately worn monthly contact 
lenses for 3 months, cleaned and rinsed 
lenses with a commercial cleaning 
solution but diluted the solution with 
tap water, and washed her hands with 
tap water but did not dry them before 
handling the lenses.
Results of microbiologic analysis 
of a corneal scraping, which included 
molecular detection of ameba (18S 
rDNA), bacteria (16S rDNA), and 
herpesvirus (DNA polymerase), 
were negative. However, culture 
of contact lens storage case liquid 
in Page-modiﬁ   ed Neff ameba 
saline enriched with heat-killed 
Enterobacter aerogenes (2) identiﬁ  ed 
Pseudomonas  ﬂ  uorescens and 
Stenotrophomonas maltophilia, both 
of which were identiﬁ  ed by matrix-
assisted laser desorption ionization 
time-of-ﬂ  ight mass spectrometry (4); 
Mycobacterium chelonae, which was 
identiﬁ  ed by rpoB gene sequencing; 
and Acanthamoeba polyphaga, which 
was identiﬁ   ed by partial 18S rDNA 
sequencing.
Culturing this ameba in sterile 
peptone–yeast extract–glucose broth 
showed that it hosted 4 organisms. The 
ﬁ  rst organism was a new intracellular 
Deltaproteobacterium provisionally 
named Candidatus Babela massiliensis 
(100% 16S rDNA sequence similarity 
with a reference strain [GenBank 
accession no. GQ495224], which 
was susceptible to 200 μg/mL 
rifampin and resistant to 20 μg/mL 
ciproﬂ  oxacin). The second organism 
was a new, unnamed, gram-negative, 
ciproﬂ  oxacin-susceptible (20 μg/mL) 
Alphaproteobacterium bacillus with 
99% 16S rDNA sequence similarity 
(GenBank accession no. HM138368) 
with  Candidatus Odyssella sp. and 
Acanthamoeba endosymbiont KA/
E9 (5). The third organism was a new 
giant virus related to an A. polyphaga 
mimivirus (6) strain Lentille. The 
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